ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

Chemo Can Harm Liver, Affect Surgical Outcomes

May 26, 2006

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

April 3, 1998

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981

Loehrer To Direct IU Simon Cancer Center

March 5, 2010

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999